loadpatents
name:-0.0030219554901123
name:-0.027779817581177
name:-0.00054788589477539
Skotnicki; Jerauld S. Patent Filings

Skotnicki; Jerauld S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Skotnicki; Jerauld S..The latest application filed is for "beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase".

Company Profile
0.22.1
  • Skotnicki; Jerauld S. - Allentown NJ
  • Skotnicki; Jerauld S. - Westfield NJ
  • Skotnicki; Jerauld S. - Chadds Ford PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Rapamycin hydroxyesters
Grant RE44,768 - Skotnicki , et al. February 18, 2
2014-02-18
Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
Grant 7,795,252 - Graziani , et al. September 14, 2
2010-09-14
Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
Grant 7,595,327 - Levin , et al. September 29, 2
2009-09-29
Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
App 20060211730 - Levin; Jeremy I. ;   et al.
2006-09-21
Carbamates of rapamycin
Grant 5,567,709 - Skotnicki , et al. October 22, 1
1996-10-22
Carbamates of rapamycin
Grant 5,559,112 - Skotnicki , et al. September 24, 1
1996-09-24
Rapamycin amidino carbamates
Grant 5,541,191 - Skotnicki , et al. July 30, 1
1996-07-30
Carbamates of rapamycin
Grant 5,532,355 - Skotnicki , et al. July 2, 1
1996-07-02
Rapamycin amidino carbamates
Grant 5,508,286 - Skotnicki , et al. April 16, 1
1996-04-16
Rapamycin amidino carbamates
Grant 5,463,048 - Skotnicki , et al. October 31, 1
1995-10-31
Carbamates of rapamycin
Grant 5,434,260 - Skotnicki , et al. July 18, 1
1995-07-18
Phosphorylcarbamates of rapamycin and oxime derivatives thereof
Grant 5,391,730 - Skotnicki , et al. February 21, 1
1995-02-21
Rapamycin hydroxyesters
Grant 5,362,718 - Skotnicki , et al. November 8, 1
1994-11-08
Substituted tetrahydropyrido[3',4':4,5]-pyrrolo[3,2-c]quinolines
Grant 5,281,608 - Skotnicki , et al. January 25, 1
1994-01-25
Macrocyclic immunomodulators
Grant 5,252,579 - Skotnicki , et al. October 12, 1
1993-10-12
1-Substituted-4-pyrrolidinopiperidines as inhibitors of interleukin 1
Grant 4,902,800 - Skotnicki February 20, 1
1990-02-20
2-amino-3-cyano-bicyclic pyridines/pyrazines as inhibitors of interleukin 1
Grant 4,902,685 - Skotnicki February 20, 1
1990-02-20
Substituted 1,2-dihydro-4h-3,1-benzoxazin-4-one derivatives inhibitors of interleukin 1
Grant 4,894,374 - Skotnicki , et al. January 16, 1
1990-01-16
Cyclohexylquinolines as inhibitors of interleukin 1
Grant 4,851,536 - Skotnicki , et al. July 25, 1
1989-07-25
10-Substituted benzo[b][1,6]naphthyridines as inhibitors of interleukin 1
Grant 4,816,464 - Gilman , et al. March 28, 1
1989-03-28
2-Arylbenzo(b)(1,6)naphthyridines as inhibitors of interleukin 1
Grant 4,808,612 - Skotnicki , et al. February 28, 1
1989-02-28
C-3'thioiminosulfonyl cephalosporin analogs
Grant 4,728,734 - Skotnicki , et al. March 1, 1
1988-03-01
C-3' acylaminooxy-7-[(2-aminothiazol-4-yl)-.alpha.-(substituted-oximino)acety l]cephalosporin derivatives
Grant 4,692,517 - Skotnicki , et al. September 8, 1
1987-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed